Business Description
Genix Pharmaceuticals Corp
NAICS : 325412
SIC : 3741
ISIN : CA37232A1093
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -5.86 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -135.57 | |||||
Beneish M-Score | -16.73 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -109.1 | |||||
3-Year EPS without NRI Growth Rate | 15.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 98.29 | |||||
14-Day RSI | 92.84 | |||||
12-1 Month Momentum % | -11.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.14 | |||||
Quick Ratio | 0.04 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 58546 | |||||
Days Sales Outstanding | 474.5 | |||||
Days Payable | 97820 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -13.96 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75 | |||||
Operating Margin % | -10325 | |||||
Net Margin % | -99925 | |||||
FCF Margin % | -5066.67 | |||||
ROA % | -417.05 | |||||
ROIC % | -21.94 | |||||
3-Year ROIIC % | 4.43 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.72 | |||||
EV-to-EBITDA | -0.75 | |||||
EV-to-Revenue | 700.5 | |||||
EV-to-FCF | -13.47 | |||||
Earnings Yield (Greenblatt) % | -138.89 | |||||
FCF Yield % | -10.03 |